This study evaluated the performance of PATH’s rapid diagnostic assay detecting histidine rich protein 2 (HRP-2) antigen when used by local health care providers in a rural field setting in Lao PDR and examined rapid diagnostic assays as a strategy to identify participants for in vivo treatment trials in a rural field site.